Frequently Asked Questions
The market is segmented based on , By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High, Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others) – Industry Trends and Forecast to 2030.
.
The Global Topical Corticosteroids Market size was valued at USD 3996.91 USD Million in 2022.
The Global Topical Corticosteroids Market is projected to grow at a CAGR of 6.1% during the forecast period of 2023 to 2030.
The major players operating in the market include Gsk plc, Almirall S.A, Merck & Co. , Bausch Health, Sandoz International GmbH, Pfizer , AstraZeneca, Sanofi, Bayer AG, McKesson Corporation, Regeneron Pharmaceuticals , Medtronic, AbbVie , GALDERMA LABORATORIES L.P., Novartis AG, LEO Pharma A/S, Cipla , Johnson & Johnson Services , Bristol-Myers Squibb Company, Mylan N.V.
.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
